The Emerging Role of Poly(ADP-Ribose) Polymerase Inhibitors in Cancer Treatment

E-ISSN： 1873-5592|12|14|2034-2044

ISSN： 1389-4501

Source： Current Drug Targets, Vol.12, Iss.14, 2011-01, pp. : 2034-2044

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Poly(ADP-Ribose) Polymerase Inhibitors

Current Medicinal Chemistry, Vol. 10, Iss. 4, 2003-01 ,pp. : 321-340

Bentham Science Publishers

Access to resources Recommend Favorite

Poly(ADP)-Ribose Polymerase-1 Inhibitors as a Potential Treatment for Cocaine Addiction

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 14, Iss. 6, 2015-08 ,pp. : 727-730

Bentham Science Publishers

Access to resources Recommend Favorite

New inhibitors of poly(ADP-ribose) polymerase (PARP)

By Peukert Stefan Schwahn Uwe

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 11, 2004-11 ,pp. : 1531-1551

Informa Healthcare

Access to resources Recommend Favorite

Poly(ADP-ribose) polymerase inhibitors in the prevention of neuronal cell death

By Larner Andrew J

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 4, 2002-04 ,pp. : 481-487

Informa Healthcare

Access to resources Recommend Favorite

New inhibitors of poly(ADP-ribose) polymerase and their potential therapeutic targets

By Cosi Cristina

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 7, 2002-07 ,pp. : 1047-1071

Informa Healthcare

Access to resources Recommend Favorite